Clinical trials
Every registered trial of Pemvidutide
15 studies.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Very little human research on Pemvidutide has been registered.
- 15 registered studies in total.
- None are currently enrolling — this research has already happened.
What kind of research
- 15 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 1,315 people took part in those.
How far along it is
- None have reached phase 3 — the large, late-stage trials where a drug has to prove itself before regulators will approve it.
- 4 have published results in the medical literature that anyone can read.
- The research spans 3 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.